We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$697M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-13.06%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$146M
AUM Growth
-$56.5M
(-28%)
Cap. Flow
-$25.8M
Cap. Flow
% of AUM
-17.71%
Top 10 Holdings %
Top 10 Hldgs %
57.31%
Holding
49
New
10
Increased
16
Reduced
6
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NEOS
Neos Therapeutics, Inc
NEOS
|
+$14.7M |
| 2 |
QTNT
Quotient Limited Ordinary Shares
QTNT
|
+$7.61M |
| 3 |
UnitedHealth
UNH
|
+$6.7M |
| 4 |
Sanofi
SNY
|
+$6.68M |
| 5 |
United Therapeutics
UTHR
|
+$6.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$10.6M |
| 2 |
Addus HomeCare
ADUS
|
+$5.18M |
| 3 |
AET
Aetna Inc
AET
|
+$5.1M |
| 4 |
PETX
Aratana Therapeutics, Inc.
PETX
|
+$4.48M |
| 5 |
Stryker
SYK
|
+$3.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.97% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HNGR
26
DELISTED
Hanger Inc.
HNGR
| $1.25M | 0.86% |
91,995
-83,864
| -48% | -$1.61M |
|
|
PETX
27
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.19M | 0.81% |
140,156
-264,582
| -65% | -$4.48M |
|
28
SCYNEXIS
SCYX
$37.4M
| $1.18M | 0.81% |
2,027
| – | – |
|
29
Ironwood Pharmaceuticals
IRWD
$586M
| $1.12M | 0.77% |
128,236
-154,742
| -55% | -$1.44M |
|
|
AGRX
30
DELISTED
Agile Therapeutics
AGRX
| $536K | 0.37% |
40
+9
| +29% | +$160K |
|
31
InspireMD
NSPR
$31.4M
| – | – |
0
| – | – |
|
|
IMNP
32
DELISTED
Immune Pharmaceuticals Inc.
IMNP
| $233K | 0.16% |
+9,883
| New | +$311K |
|
|
CXRX
33
DELISTED
Concordia International Corp. Common Stock
CXRX
| $221K | 0.15% |
+5,201
| New | +$385K |
|
|
BSTG
34
DELISTED
Biostage, Inc. Common Stock
BSTG
| $99K | 0.07% |
116,593
-116,119
| -50% | -$132K |
|
35
PUT
Abbott
ABT
$187B
| – | – |
-50,000
| Closed | -$2.45M |
|
|
36
Addus HomeCare
ADUS
$2.22B
| – | – |
-186,055
| Closed | -$5.18M |
|
|
AVNS
37
DELISTED
Avanos Medical
AVNS
| – | – |
-60,000
| Closed | -$2.43M |
|
38
PUT
Gilead Sciences
GILD
$165B
| – | – |
-500,000
| Closed | -$58.5M |
|
|
39
GSK
GSK
$107B
| – | – |
-204,000
| Closed | -$10.6M |
|
|
40
PUT
GSK
GSK
$107B
| – | – |
-40,000
| Closed | -$2.08M |
|
41
PUT
Johnson & Johnson
JNJ
$640B
| – | – |
-30,000
| Closed | -$2.92M |
|
42
PUT
Eli Lilly
LLY
$1.08T
| – | – |
-30,000
| Closed | -$2.5M |
|
43
PUT
Medtronic
MDT
$112B
| – | – |
-30,000
| Closed | -$2.22M |
|
44
PUT
Pfizer
PFE
$143B
| – | – |
-158,100
| Closed | -$5.03M |
|
|
45
Stryker
SYK
$135B
| – | – |
-33,300
| Closed | -$3.18M |
|
46
Zevra Therapeutics
ZVRA
$578M
| – | – |
-1,721
| Closed | -$506K |
|
|
ALBO
47
DELISTED
Albireo Pharma Inc
ALBO
| – | – |
-5,351
| Closed | -$165K |
|
|
IMMU
48
PUT
DELISTED
Immunomedics Inc
IMMU
| – | – |
-664,900
| Closed | -$2.7M |
|
|
AET
49
DELISTED
Aetna Inc
AET
| – | – |
-40,000
| Closed | -$5.1M |
|
Similar funds
GUB
KLI
JA
WIC
AAM
TCM
CA
SAM
Sio Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Sio Capital Management held 49 positions worth $146M, down 28% from $202M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Sio Capital Management withdrew a net $25.8M in Q3 2015, closing 15 positions and reducing 6 holdings. Its most notable exit was GSK, an estimated $10.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 55% a quarter earlier, followed by Financials.
Against the trend, Sio Capital Management opened a new position in Neos Therapeutics, Inc worth $14M.
- Sio Capital Management's largest Q3 2015 buy was Neos Therapeutics, Inc: 666,729 shares worth $14M.
- Sio Capital Management added most to Quotient Limited Ordinary Shares in Q3 2015, an estimated $7.61M increase.
- Sio Capital Management's biggest Q3 2015 reduction was Aratana Therapeutics, Inc., cutting an estimated $4.48M.
- Sio Capital Management fully exited GSK in Q3 2015, selling an estimated $10.6M.
- Sio Capital Management's ten largest holdings make up 57% of its $146M portfolio in Q3 2015.
- Sio Capital Management opened 10 new positions and closed 15 in Q3 2015.
- Sio Capital Management's portfolio value fell 28% quarter-over-quarter to $146M.
Based on Sio Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.